Rate and Predictors of Endoscopic Mucosal Healing in Biologic Naive Patients with Inflammatory Bowel Disease by Azathioprine Treatment: A Real World, 10 Years’ Experience from a Single Centre in Turkey.

Basaranoglu M, Ertan A, Mathew S, Najjar SM, Ala A, Demirbag AE, Senturk H.

J Gastrointest Dig Syst. 2016 Aug;6(4). pii: 467. doi: 10.4172/2161-069X.1000467. Epub 2016 Aug 31.

PMID: 29057149


Low lipase levels as an independent marker of pancreatic cancer: a frequently neglected condition in clinical setting.

Gültepe İ, Başaranoğlu M, Zorlu M, Şenyiğit A, Taşkale EZ, Zaralı S, Atay K, Köroğlu E.

Turk J Gastroenterol. 2016 Mar;27(2):197-200. doi: 10.5152/tjg.2016.16056.



Significant cohort of non-alcoholic fatty liver disease with portal vein thrombosis in transplant waiting list.

Basaranoglu M, Najjar SM, Demirbag AE, Senturk H.

World J Hepatol. 2016 Mar 8;8(7):376-84. doi: 10.4254/wjh.v8.i7.376.



Ovaries are more vulnerable than hepatocytes for insulin resistance and hyperinsulinemia.

Gültepe İ, Başaranoğlu M, Süleymanoğlu Y, Başaranoğlu G, Beyazıt F.

Turk J Gastroenterol. 2016 Jan;27(1):62-7. doi: 10.5152/tjg.2015.150473.



Two cases with Plummer-Vinson syndrome in the 21st century.

Gültepe İ, Başaranoğlu M.

Turk J Gastroenterol. 2016 Jan;27(1):81-2. doi: 10.5152/tjg.2015.150435. Epub 2015 Nov 27. Review.



Mallory-Denk bodies: Correlation with steatosis, severity, zonal distribution, and identification with ubiquitin.

Kayaçetin S, Başaranoğlu M.

Turk J Gastroenterol. 2015 Nov;26(6):506-10. doi: 10.5152/tjg.2015.150199. Epub 2015 Oct 22.



The rate of mucosal healing by azathioprine therapy and prediction by artificial systems.

Hardalaç F, Başaranoğlu M, Yüksel M, Kutbay U, Kaplan M, Özderin Özin Y, Kılıç ZM, Demirbağ AE, Coşkun O, Aksoy A, Gangarapu V, Örmeci N, Kayaçetin E.

Turk J Gastroenterol. 2015 Jul;26(4):315-21. doi: 10.5152/tjg.2015.0199. Epub 2015 Jun 2.



Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction.

Basaranoglu M, Basaranoglu G, Bugianesi E.

Hepatobiliary Surg Nutr. 2015 Apr;4(2):109-16. doi: 10.3978/j.issn.2304-3881.2014.11.05. Review.



Characterization of de novo colonic stricture due to Crohn’s disease.

Başaranoğlu M, Sayılır A, Yüksel M, Yıldız H, Suvak B, Turhan N, Tunç B, Özin Y.

Turk J Gastroenterol. 2014 Dec;25 Suppl 1:129-32. doi: 10.5152/tjg.2014.7677.



The seroprevalence of both hepatitis B and hepatitis C at the first-step health organizations and the difference between the urban and rural areas.

Kalem F, Yüksekkaya Ş, Başaranoğlu M.

Wien Klin Wochenschr. 2016 Oct;128(19-20):695-699. Epub 2015 Apr 14.



Nonalcoholic fatty liver may increase the risk of operation in patients with fatty liver and the frequency of cancer in their first-degree relatives.

Basaranoglu M, Canbakan B, Yildiz K, Ceylan B, Baysal B, Uysal O, Senturk H.

Wien Klin Wochenschr. 2016 Oct;128(19-20):691-694. Epub 2015 Apr 14.



Seasonal clustering in inflammatory bowel disease: a single centre experience.

Basaranoglu M, Sayilir A, Demirbag AE, Mathew S, Ala A, Senturk H.

Expert Rev Gastroenterol Hepatol. 2015 Jun;9(6):877-81. doi: 10.1586/17474124.2015.1025054. Epub 2015 Mar 19.



Author’s reply: To PMID 25003670.

Başaranoğlu M, Örmeci N.

Turk J Gastroenterol. 2014 Aug;25(4):468-9. No abstract available.



Nonalcoholic fatty liver disease: diagnosis, pathogenesis, and management.

Başaranoğlu M, Örmeci N.

Turk J Gastroenterol. 2014 Apr;25(2):127-32. doi: 10.5152/tjg.2014.7675. Review.



From fatty liver to fibrosis: a tale of “second hit”.

Basaranoglu M, Basaranoglu G, Sentürk H.

World J Gastroenterol. 2013 Feb 28;19(8):1158-65. doi: 10.3748/wjg.v19.i8.1158. Review.



Fructose as a key player in the development of fatty liver disease.

Basaranoglu M, Basaranoglu G, Sabuncu T, Sentürk H.

World J Gastroenterol. 2013 Feb 28;19(8):1166-72. doi: 10.3748/wjg.v19.i8.1166. Review.



The utility of amylase and lipase as reliable predictive markers for functioning renal graft.

Yilmaz UE, Yilmaz N, Titiz I, Basaranoglu M, Tarcin O.

Ann Transplant. 2012 Jul-Sep;17(3):77-84.


Dietary trans-fatty acid induced NASH is normalized following loss of trans-fatty acids from hepatic lipid pools.

Neuschwander-Tetri BA, Ford DA, Acharya S, Gilkey G, Basaranoglu M, Tetri LH, Brunt EM.

Lipids. 2012 Oct;47(10):941-50. Epub 2012 Aug 26.



Ankaferd hemostat in the management of gastrointestinal hemorrhages.

Beyazit Y, Kekilli M, Haznedaroglu IC, Kayacetin E, Basaranoglu M.

World J Gastroenterol. 2011 Sep 21;17(35):3962-70. doi: 10.3748/wjg.v17.i35.3962.



Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis.

Basaranoglu M, Basaranoglu G.

World J Gastroenterol. 2011 Sep 28;17(36):4055-62. doi: 10.3748/wjg.v17.i36.4055. Review.



Mallory-Denk Bodies in chronic hepatitis.

Basaranoglu M, Turhan N, Sonsuz A, Basaranoglu G.

World J Gastroenterol. 2011 May 7;17(17):2172-7. doi: 10.3748/wjg.v17.i17.2172. Review.



Time course of collagen peak in bile duct-ligated rats.

Tarcin O, Basaranoglu M, Tahan V, Tahan G, Sücüllü I, Yilmaz N, Sood G, Snyder N, Hilman G, Celikel C, Tözün N.

BMC Gastroenterol. 2011 Apr 28;11:45. doi: 10.1186/1471-230X-11-45.



Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease.

Basaranoglu M, Kayacetin S, Yilmaz N, Kayacetin E, Tarcin O, Sonsuz A.

World J Gastroenterol. 2010 May 14;16(18):2223-6. Review.



Chemotherapy-induced Hepatitis B virus reactivation in HbsAg positive cancer patients: a single center experience.

Eren OO, Artac M, Boruban MC, Yavas O, Arslan U, Basaranoglu M.

Med Oncol. 2009 Dec;26(4):386-92. doi: 10.1007/s12032-008-9133-4. Epub 2008 Nov 20.



Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent.

Tetri LH, Basaranoglu M, Brunt EM, Yerian LM, Neuschwander-Tetri BA.

Am J Physiol Gastrointest Liver Physiol. 2008 Nov;295(5):G987-95. doi: 10.1152/ajpgi.90272.2008. Epub 2008 Sep 4.



Prevalence and consultation behavior of self-reported rectal bleeding by face-to-face interview in an Asian community.

Basaranoglu M, Celebi S, Ataseven H, Rahman S, Deveci SE, Acik Y.

Digestion. 2008;77(1):10-5. doi: 10.1159/000114827. Epub 2008 Jan 30.



Seasonality of the onset of symptoms, tuberculin test anergy and Kveim positive reaction in a large cohort of patients with sarcoidosis.

Demirkok SS, Basaranoglu M, Coker E, Karayel T.

Respirology. 2007 Jul;12(4):591-3.



Analysis of 275 patients with sarcoidosis over a 38 year period; a single-institution experience.

Demirkok SS, Basaranoglu M, Akinci ED, Karayel T.

Respir Med. 2007 Jun;101(6):1147-54. Epub 2006 Dec 26.



Case study on drug-related adverse effects of hepatitis C therapy.

Basaranoglu M, Celebi S, Karaaslan H, Demir A.

Adv Ther. 2006 Sep-Oct;23(5):769-71.



Symptom date is better than the endoscopic diagnosis date in seasonal variation studies in IBD.

Basaranoglu M.

Am J Gastroenterol. 2006 Nov;101(11):2668-9. No abstract available.



A splenic hydatid cyst case presented with lumbar pain.

Celebi S, Basaranoglu M, Karaaslan H, Demir A.

Intern Med. 2006;45(17):1023-4. Epub 2006 Oct 2.



A true fundic diverticulum of the gallbladder.

Basaranoglu M, Balci NC.

J Gastroenterol Hepatol. 2006 Jul;21(7):1222-3. No abstract available.



Analysis of 87 patients with Löfgren’s syndrome and the pattern of seasonality of subacute sarcoidosis.

Sipahi Demirkok S, Basaranoglu M, Dervis E, Bal M, Karayel T.

Respirology. 2006 Jul;11(4):456-61.



Nonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis.

Basaranoglu M, Neuschwander-Tetri BA.

Gastroenterol Hepatol (N Y). 2006 Apr;2(4):282-291.



Gallbladder sludge and acute pancreatitis induced by acute hepatitis A.

Basaranoglu M, Balci NC, Klör HU.

Pancreatology. 2006;6(1-2):141-4. Epub 2005 Dec 13.


Recurrent cholangitis associated with biliary sludge and Phrygian cap anomaly diagnosed by magnetic resonance imaging and magnetic resonance cholangiopancreatography despite normal ultrasound and computed tomography.

Basaranoglu M, Balci NC.

Scand J Gastroenterol. 2005 Jun;40(6):736-40.



The fluctuation of serum levels of aminotransferase in patients with nonalcoholic steatohepatitis.

Ipekci SH, Basaranoglu M, Sonsuz A.

J Clin Gastroenterol. 2003 Apr;36(4):371. No abstract available.



Serum levels of triglyceride and insulin resistance in patients with nonalcoholic steatohepatitis.

Basaranoglu M.

Can J Gastroenterol. 2002 Nov;16(11):813-4; author reply 814. No abstract available.



Hyperinsulinemia in nondiabetic, both obese and nonobese patients with nonalcoholic steatohepatitis.

Sonsuz A, Basaranoglu M, Bilir M, Senturk H, Akin P.

Am J Gastroenterol. 2002 Feb;97(2):495. No abstract available.